Promising discovery for patients with diabetic retinopathy

Promising discovery for patients with diabetic retinopathy
Diabetic retinopathy. Credit: Centre de recherche de l'Hôpital Maisonneuve-Rosemont

Published in the journal Science, a new study has shed light on a cellular process that occurs in the retinas of people with diabetic retinopathy. This discovery could lead to the development of a treatment for this serious complication of diabetes.

The research was led by Dr. Przemyslaw (Mike) Sapieha and Dr. François Binet in collaboration with Dr. Frédérick Antoine Mallette and Dr. Flavio Rezende of the Center de recherche de l'Hôpital Maisonneuve-Rosemont (CR-HMR), which is part of the Center intégré universitaire de santé et de services sociaux de l'Est-de-l'Île-de-Montréal, and Dr. Jean-Sébastien Joyal of the CHU Sainte-Justine Research Center, affiliated with Université de Montréal and also with Dr. Jean-François Côté of the Montreal Clinical Research Institute (IRCM).

Diabetic retinopathy is characterized by vascular degeneration and later the formation of abnormal in the retina. This vascular proliferation compromises the that carry information from the eyes to the brain.

The study demonstrates that to stop abnormal vascular proliferation, vessels apply a series of molecular "brakes" that become activated in a way similar to an accelerated version of natural cellular aging. Collectively, these mechanisms culminate in a process called , which eventually causes tissue scarring in the retina.

When in senescence mode, blood vessels produce inflammatory molecules that become targets of immune cells called neutrophils. Although thought to be the immune system's first responders, the study shows that neutrophils arrive in the retina later on to help clean and remodel damaged blood vessels. They do this through an unconventional cellular mechanism of releasing neutrophil extracellular traps (or NETS) made up of their own DNA onto diseased blood vessels.

Diabetic retinopathy. Credit: Centre de recherche de l'Hôpital Maisonneuve-Rosemont

More broadly, the results of this study imply that the destruction of senescent blood vessels leads to beneficial vascular remodeling. The study therefore provides insight into the general function of endothelial cells and how they predispose older populations to complications such as myocardial infarction, atherosclerosis and strokes.

Promising discovery for patients with diabetic retinopathy
Diabetic retinopathy. Credit: Centre de recherche de l'Hôpital Maisonneuve-Rosemont

Explore further

Retinopathy: Senescence-associated secretory phenotype contributes to pathological angiogenesis

More information: Neutrophil extracellular traps target senescent vasculature for tissue remodeling in retinopathy, Science (2020). science.sciencemag.org/cgi/doi … 1126/science.aay5356
Journal information: Science

Provided by Centre intégré universitaire de santé et de services sociaux de l'Est-de-l'Île-de-Montréal
Citation: Promising discovery for patients with diabetic retinopathy (2020, August 20) retrieved 26 October 2020 from https://medicalxpress.com/news/2020-08-discovery-patients-diabetic-retinopathy.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
155 shares

Feedback to editors

User comments